Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma

9Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

High recurrence rates and poor survival of patients with esophageal squamous cell carcinoma (ESCC) after treatment make ongoing research on chemoprevention drugs for ESCC particularly important. In this study, we screened a large number of FDA-approved drugs and found levodopa, a drug used to treat Parkinson’s disease, had an inhibitory effect on the growth of ESCC cells. To elucidate the molecular mechanisms involved, we applied quantitative proteomics to investigate the anti-tumor activity of levodopa on ESCC. The results suggest that levodopa could down-regulate oxidative phosphorylation, non-alcoholic fatty liver disease, and Parkinson’s disease pathways. Major mitochondrial respiratory compounds were involved in the pathways, including succinate dehydrogenase subunit D, NADH-ubiquinone oxidoreductase Fe-S protein 4, and mitochondrial cytochrome c oxidase subunit 3. Down-regulation of these proteins was associated with mitochondrial dysfunction. Western blotting and immunofluorescence results confirmed the proteomics findings. Cell viability assays indicated mitochondrial activity was suppressed after levodopa treatment. Reduced mitochondrial membrane potential was detected using JC-1 staining and TMRE assays. Transmission electron microscopy revealed changes in the morphology of mitochondria. Taken together, these results indicate that levodopa inhibited the growth of ESCC through restraining mitochondria function.

References Powered by Scopus

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

66847Citations
N/AReaders
Get full text

Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes

8106Citations
N/AReaders
Get full text

Drug discovery and development: Role of basic biological research

426Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma

16Citations
N/AReaders
Get full text

Proteomics on the role of muscone in the “consciousness-restoring resuscitation” effect of musk on ischemic stroke

11Citations
N/AReaders
Get full text

L-Dihydroxyphenylalanine (L-Dopa) Induces Brown-like Phenotype in 3T3-L1 White Adipocytes via Activation of Dopaminergic and β3-adrenergic Receptors

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, Z., Li, X., He, X., Jia, X., Zhang, X., Lu, B., … Dong, Z. (2020). Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.568459

Readers' Seniority

Tooltip

Researcher 2

67%

PhD / Post grad / Masters / Doc 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

50%

Biochemistry, Genetics and Molecular Bi... 3

30%

Neuroscience 1

10%

Agricultural and Biological Sciences 1

10%

Save time finding and organizing research with Mendeley

Sign up for free